Year: 2012
Type: dissertation
Abstract: The hepadnavirus family contains two genera, Orthohepadnaviruses that infect mammals and Avihepadnaviruses that infect birds. The most thoroughly studied members of the hepadnavirus family include hepatitis B virus (HBV), which infects humans and chimpanzees, woodchuck hepatitis virus (WHV), which infects woodchucks, and duck hepatitis B virus (DHBV), which infects ducks. All hepadnaviruses have similar genome structure and organisation of the open reading frames on their genome, and also show extensive nucleotide sequence homology within, but not between, genera. All hepadnaviruses primarily infect hepatocytes and have similar infection outcomes in their natural hosts. The outcome of hepadnavirus infection can be divided into either acute, with successful clearance of infection from the host and establishment of immune control, or chronic, where infection is not cleared, resulting in persistent lifelong infection that is linked to various forms of liver disease. The mechanisms involved in immune clearance of hepadnavirus infections are poorly understood. It has been hypothesised that virus DNA and proteins are, 1) cleared from the liver cytolytically by killing of the infected hepatocytes, or 2) can be destroyed noncytolytically by cytokines, leaving the infected hepatocyte intact. In this study, the mechanism of immune clearance was explored using molecular approaches to detect integrated virus-cell junctions, formed by the integration of DHBV DNA into the duck liver genome. The rate of DHBV DNA integration is thought to be low (reported to occur at a rate of ~1 in 10³ – 10⁴ cells by 6 day post infection (dpi)) (Yang and Summers, 1999), and the site of viral DNA integration into the host cell genome is random. Hence, each integration event will produce a unique integrated virus-cell junction that can be used as a genetic marker for that cell, which allows the fate of the DHBV-infected hepatocytes to be observed in the liver during various stages of both acute and chronic DHBV infection. Integrated virus-cell junctions can be detected using inverse nested PCR (invPCR), as described by Yang and Summers (Yang and Summers, 1999). Thus, this study aimed to determine whether cytolytic or non-cytolytic clearance of infected hepatocytes occurred, with the ultimate aim of contributing knowledge to assist in the development of new therapies for patients with chronic HBV infection. Initially, several molecular assays required for the characterisation of DHBV infection and the invPCR assay were established and optimised. These included DNA sequencing reactions and subsequent purification of DNA sequencing products (Chapter 3.1), quantitative PCR (qPCR) assays used for the detection of DHBV total and cccDNA (Chapter 3.2), as well as cloning and sequencing of the duck beta actin (β actin) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) genes. The latter were both used as internal controls in the qPCR assays to quantify levels of DHBV total and cccDNA per cell (Chapter 4). Several parameters were tested and compared for each molecular assay to generate final optimised protocols, which were then applied both throughout subsequent Chapters and in other work performed in the laboratory. The duck β actin and GAPDH genes were characterised and the sequences were submitted to GenBank (GenBank Accession GU564232 and GU564233 respectively). The invPCR protocol was optimised by comparing 8 different liver cell DNA extraction methods, to determine the method that most efficiently extracted high molecular weight (MW) DNA from small quantities of frozen liver (Chapter 5.1). One of the major problems with the invPCR assay was the high level of virus-virus (false positive) sequences generated from replicative forms of virus DNA. Therefore, the use of locked nucleic acids (LNA) oligonucleotides that were specific for the DHBV genome were tested as a potential selective tool to block the amplification of DHBV DNA (Chapter 5.2). LNA oligonucleotides can bind with high affinity to their complementary DNA sequence, forming high melting temperature LNA-DNA complexes which then block amplification of that DNA sequence. Although the LNAs successfully blocked amplification of virus DNA, due to the high cost of LNA, their use in invPCR assays could not be pursued in this thesis. As a possible alternative to the invPCR assay, a linker ligation assay was assessed for its ability to detect integrated virus-cell junctions in samples of WHV-infected woodchuck and DHBV-infected duck liver tissue (Chapter 5.3). However, as the efficiency of detection of integrated virus-cell junctions using linker ligation assay was similar to the efficiency of the invPCR assay, it was not further developed in this thesis, as the linker ligation assay is more complicated and time-consuming than invPCR. After optimising all the required molecular assays required for the invPCR assay in previous Chapters, the invPCR assay was first performed on plasmid DNA constructs as model systems, in order to determine the sensitivity and efficiency of the assay (Chapter 5.4). It was found that the invPCR assay was able to amplify from a single copy of DNA template. The invPCR assay was also performed on samples of WHV-infected woodchuck and HBVinfected chimpanzee liver tissue in collaboration with Dr. William Mason (Chapter 5.5). The results of the invPCR assay results confirmed that the assays established in this study had comparable efficiency with previously published invPCR assays, and could be confidently applied in this thesis. The integrated virus-cell junctions obtained in this study were included as a subset of the data published by Mason et al. 2009a and 2009b. In order to establish an invPCR assay specifically for the AusDHBV strain (GenBank Accession AJ006350), several DHBV invPCR assays were designed, and preliminary studies were performed on liver tissues collected previously in the laboratory from ducks with acute and chronic DHBV infection (Chapter 6). Up to 38 integrated virus-cell junctions were successfully detected, among which 3 junctions were repeated, suggesting that clonal proliferation of hepatocytes had occurred in the duck liver. Characterisation of the integrated DHBV DNA showed that, consistent to previous studies, the most probable left and right hand end of the integrated DHBV dslDNA was at nucleotide position 2537 nt and ~2485 nt respectively, with no significant patterns or apparent preference of DHBV integration sites in the duck genome. The duck invPCR assay was subsequently extensively used in Chapters 7 and 8. To achieve the main aim of this thesis, and to explore if cytolytic or non-cytolytic clearance occurs during the resolution of acute hepadnavirus infection, the invPCR assay was used to detect integrated virus-cell junctions during and after resolution of acute DHBV infection. This DHBV model provided an advantage over the WHV-infected woodchuck and the HBVinfected chimpanzee models, where hepadnavirus infection spreads to >95% of the hepatocytes in the liver. Widespread infection requires the division of infected hepatocytes during clearance to replace hepatocytes killed by the host immune response. But in the duck model, DHBV infection can be established in ducks by inoculation with defined doses of DHBV to achieve a maximum DHBV infection of <10% of the hepatocytes prior to immune clearance. Therefore, when the few DHBV-infected hepatocytes were killed, they would be most likely be replaced by division of uninfected hepatocytes. It is thus expected that if cytolytic hepatocyte killing was the predominant response to DHBV infection, the integrated virus-cell junctions would not be detected in the recovered liver, as the infected hepatocytes would be destroyed and replaced by previously uninfected hepatocytes. Conversely, if noncytolytic hepatocyte curing was predominant, them integrated virus-cell junctions would still be detected after clearance of infection as they would be present in the cellular genome of the “cured” hepatocytes. Using AusDHBV, acute DHBV infections were established in 3, 6-week-old ducks (Chapter 7). At 4 dpi, active DHBV replication was occurring (159 and 3.6 copies of DHBV total and cccDNA per infected hepatocyte) with ~4.4% of DHBV surface antigen (DHBsAg)-positive hepatocytes in the liver. At 45 dpi, <0.001% of hepatocytes were DHBsAg-positive, with residual DHBV DNA predominantly in the cccDNA form (~0.02 copies and ~0.01 copies of DHBV total and cccDNA per liver cell). Histological characterisation of liver tissues showed elevated levels of portal and lobular liver inflammation, hepatocyte apoptosis, and Kupffer cell infiltration and activation during clearance of infection (4 and 18 dpi), returning to “basal” levels after clearance (45 dpi). Serological characterisation revealed anti-DHBc antibodies by 4 dpi and anti-DHBs antibodies by 11 dpi. The neutralising anti-DHBs antibodies would have removed DHBV virions from the serum by forming antibody-antigen complexes to reduce the levels of viraemia, as only 2x10⁶ copies of DHBV DNA was detected per mL of serum at 11 and 14 dpi. The anti-DHBs antibodies were also continuously produced at high levels after resolution of infection (45 dpi), providing protection against further DHBV infection. Using the invPCR assay, up to 24.3 μg of DNA was analysed from liver tissues at 4, 18 and 45 dpi. However, no integrated virus-cell junctions were detected at any stages of acute DHBV infection out of the 286 invPCR products sequenced. Up to 75.5% of the invPCR products sequenced were found to be virus-virus (false positive) sequences. As DHBV DNA integration has been reported to occur at a rate of ~1 in 10³ – 10⁴ cells by 6 dpi (Yang and Summers, 1999), out of the 9.7x10⁶ cells analysed in this study, ~4.4% of which were DHBsAg-positive, it was expected that at least 40 – 400 integrated virus-cell junctions would be detected, assuming that the DHBV-infected hepa
Author: Huey Chi Low
Language: English
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3003177966
